Skip to content
Home/Companies/Biotech/Galecto Biotech

Galecto Biotech

Biotech·Denmark·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Galecto Biotech?

Galecto Biotech is currently owned by Seventure Partners through Quadrivium 1 Seed Fund (2013 vintage), since 2018. Across its history, Galecto Biotech has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Seventure Partners
Most recent investor
Seventure Partners
Quadrivium 1 Seed Fund · 2013 · VC
2 ownership periods · full history below

Key facts

HQDenmark
SectorBiotech

Ownership history

2 ownership periods · co-invest detected

Active
Currently held by Seventure Partners since 2018.
Co-invest · 2 holders · 2018 · present
Ysios Capital Partners
2018 · 2020(2yr) · Ysios BioFund I · 2008 · Life Sciences VC
IPO
MOIC
Seventure Partners
2018 · present(8yr) · Quadrivium 1 Seed Fund · 2013 · VC
Track Galecto Biotech

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Galecto Biotech?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Galecto Biotech.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue